Case Study

IV Myeloma Indication / Combination Expansion Pricing Evolution Strategy

magnifying glass hero

Download the case study to learn how the Dedham Group advised a large pharmaceutical manufacturer on their pricing approach for their on-market 4L Multiple Myeloma therapy once it expands into earlier line combination with a novel oral GSI.

Download the Case Study